Related references
Note: Only part of the references are listed.Recent advances in drug delivery systems for targeting cancer stem cells
Hongxia Duan et al.
ACTA PHARMACEUTICA SINICA B (2021)
HAMLET a human milk protein-lipid complex induces a pro-inflammatory phenotype of myeloid cells
Goutham Vansarla et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2021)
Gastric Cancer: Advances in Carcinogenesis Research and New Therapeutic Strategies
Lornella Seeneevassen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Casein Kinase-1-Alpha Inhibitor (D4476) Sensitizes Microsatellite Instable Colorectal Cancer Cells to 5-Fluorouracil via Authophagy Flux Inhibition
Morvarid Siri et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2021)
Characterization of CD44-positive Cancer Stem-like Cells in COLO 201 Cells
Hirohisa Okuyama et al.
ANTICANCER RESEARCH (2020)
5-FU promotes stemness of colorectal cancer via p53-mediated WNT/β-catenin pathway activation
Yong-Hee Cho et al.
NATURE COMMUNICATIONS (2020)
Cancer Stem Cell (CSC) Inhibitors in Oncology-A Promise for a Better Therapeutic Outcome: State of the Art and Future Perspectives
Prashant S. Kharkar
JOURNAL OF MEDICINAL CHEMISTRY (2020)
CD44 as a tumor biomarker and therapeutic target
Hanxiao Xu et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2020)
The Role and Specific Mechanism of OCT4 in Cancer Stem Cells: A Review
Qi Zhang et al.
INTERNATIONAL JOURNAL OF STEM CELLS (2020)
Comprehensive review of targeted therapy for colorectal cancer
Yuan-Hong Xie et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Therapeutic potential of targeting the Wnt/β-catenin signaling pathway in colorectal cancer
Xiaofei Cheng et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Emerging Roles of C-Myc in Cancer Stem Cell-Related Signaling and Resistance to Cancer Chemotherapy: A Potential Therapeutic Target Against Colorectal Cancer
Mohamed Elbadawy et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Cancer stem cells in colorectal cancer: a review
Matthew J. Munro et al.
JOURNAL OF CLINICAL PATHOLOGY (2018)
Subcellular localisation of the stem cell markers OCT4, SOX2, NANOG, KLF4 and c-MYC in cancer: a review
Bede van Schaijik et al.
JOURNAL OF CLINICAL PATHOLOGY (2018)
Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment
Lan Thi Hanh Phi et al.
STEM CELLS INTERNATIONAL (2018)
ALDH1A1 expression is associated with poor differentiation, 'right-sidedness' and poor survival in human colorectal cancer
Lizet M. van der Waals et al.
PLOS ONE (2018)
HAMLET - A protein-lipid complex with broad tumoricidal activity
James C. S. Ho et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Common stemness regulators of embryonic and cancer stem cells
Christiana Hadjimichael et al.
WORLD JOURNAL OF STEM CELLS (2015)
Enrichment of the embryonic stem cell reprogramming factors Oct4, Nanog, Myc, and Sox2 in benign and malignant vascular tumors
Clarissa N. Amaya et al.
BMC CLINICAL PATHOLOGY (2015)
Prevention and treatment of colon cancer by peroral administration of HAMLET (human α-lactalbumin made lethal to tumour cells)
Manoj Puthia et al.
GUT (2014)
Cancer stem cells: the development of new cancer therapeutics
Roberto Scatena et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2011)